Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,134 | 7,026 | -4,481 | -2,159 | -6,500 |
| Depreciation Amortization | 704 | 1,150 | 652 | 156 | 514 |
| Accounts receivable | -79 | -11 | -9 | 149 | -290 |
| Accounts payable and accrued liabilities | 283 | -102 | 125 | 309 | -150 |
| Other Working Capital | 430 | -363 | -83 | 220 | -796 |
| Other Operating Activity | 221 | -12,959 | 575 | -138 | -2,160 |
| Operating Cash Flow | $-2,575 | $-5,259 | $-3,221 | $-1,463 | $-9,382 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -12 | -8 | -2 | -637 |
| Investing Cash Flow | $-12 | $-12 | $-8 | $-2 | $-637 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,581 | 1,441 | 1,433 | 1,421 | 1,086 |
| Financing Cash Flow | $1,581 | $1,441 | $1,433 | $1,421 | $1,086 |
| Exchange Rate Effect | 42 | -11 | 121 | N/A | -272 |
| Beginning Cash Position | 2,095 | 5,010 | 5,010 | 5,010 | 14,215 |
| End Cash Position | 1,131 | 1,169 | 3,214 | 4,966 | 5,010 |
| Net Cash Flow | $-964 | $-3,841 | $-1,675 | $-44 | $-9,205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,575 | -5,259 | -3,221 | -1,463 | -9,382 |
| Capital Expenditure | -12 | -12 | -8 | -2 | -637 |
| Free Cash Flow | -2,587 | -5,271 | -3,229 | -1,465 | -10,019 |